MedPage Today on MSN

Novel Antipsychotic Shows Promise in Acute Schizophrenia

Downsides with current options leave a large unmet need for new therapies, researcher says ...

Serious mental illness is often connected to homelessness. It doesn’t have to be, Portland professor says

Shannon Blajeski explains how people with serious mental illness can live independently and not be stuck in poverty.
BioSpace

Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia study

The patient death occurred outside the U.S. and was deemed unrelated to Newron Pharmaceuticals’ investigational schizophrenia ...
Psychiatry Advisor

Schizophrenia Shows Increased Risk for Cardiac Repolarization Heterogeneity

Schizophrenia was associated with cardiac electrical instability, suggesting arrhythmic vulnerability was an intrinsic ...
Healio

FDA approves Caplyta for relapse prevention in schizophrenia

The FDA has approved Johnson & Johnson’s supplemental new drug application for Caplyta among patients with schizophrenia at ...
WBUR

You can recover from schizophrenia — I did. But the stigma of the disease prevents too many from getting treatment

"About 10% of people with schizophrenia will engage in violence during their lifetimes, which is three to four times higher than the general population, but people with schizophrenia are more likely ...
FOX 5 Atlanta on MSN

Psychologist claims Midtown shooting suspect has schizophrenia

An expert witness for the defense testified Thursday that the woman accused of a deadly shooting spree in Midtown Atlanta ...

Patient death puts Newron’s late-stage schizophrenia trial on ice

An independent international safety monitoring board has given the ENIGMA-TRS 1 trial the go-ahead to continue as planned.
WDEF

Understanding Schizophrenia And Family Impact

A closer look at schizophrenia highlights early signs, ongoing stigma, and the role families play in daily care.
Hosted on MSN

Understanding life with schizoaffective disorder

Schizoaffective disorder is a complex mental health condition that combines symptoms of schizophrenia with mood disorders like depression or bipolar disorder. Because its symptoms overlap with other ...
Neurology Advisor

Caplyta Labeling Now Includes Long-Term Schizophrenia Maintenance Data

The FDA has updated the label for Caplyta to include phase 3 data showing a significant reduction in schizophrenia relapse risk.
MPR

FDA Pauses US Enrollment for Phase 3 Evenamide Schizophrenia Study

The Food and Drug Administration (FDA) has placed a hold on the enrollment of new patients in the phase 3 ENIGMA-TRS 2 study evaluating evenamide in treatment-resistant schizophre ...